Leading Medical Device Company Selects SimpleCTMS to Optimize Management of Global Clinical Studies

OAKLAND, CA--(September 30, 2011) -  Trial By Fire Solutions, a leading eClinical solution provider specializing in clinical study management applications, today announced that a US-based developer and manufacturer of vascular disease treatments has selected SimpleCTMS to help manage their global clinical program.

SimpleCTMS will provide study management services to support the Sponsor in proactively managing its clinical program. Their current pipeline includes a number of Phase I-III studies in North America and abroad. SimpleCTMS will provide immediate data visibility to study team members and provide robust reporting for upper management needs.

"We are excited to be adding a thriving device company to our growing client base.  This organization has felt the common challenges of manual, inconsistent trackers, and we look forward to delivering a flexible and organized study management system that will be useful immediately,” said Jon Cecchettini, co-founder and CTO of Trial By Fire Solutions.

Launched in 2010, SimpleCTMS was designed and developed to offer the benefits of a CTMS (Clinical Trial Management System) without the extensive upfront financial and resource commitments associated with traditional enterprise systems or the inherent inefficiencies of worksheet trackers. Offering flexible subscription pricing, SimpleCTMS provides life science companies a scalable and cost effective solution to improve the management, performance and study startup costs associated with clinical trials.

About Trial By Fire Solutions

Trial By Fire Solutions is a life sciences focused clinical software company featuring SimpleCTMS, a flexible, intuitive and powerful clinical trial management system (CTMS). With many years of experience on the front lines of clinical trial management, we have a passion for innovating web-based eClinical technology to optimize planning, execution, tracking and overall cost of clinical trials.